NewGenIvf Group Limited (NASDAQ:NIVF) Sees Significant Drop in Short Interest

NewGenIvf Group Limited (NASDAQ:NIVF) saw a large drop in short interest in February. As of February 13th, there was short interest totaling 10,974 shares, a drop of 82.9% from the January 29th total of 64,198 shares. Currently, 1.6% of the shares of the stock are short sold. Based on an average daily volume of 1,162,246 shares, the short-interest ratio is currently 0.0 days. Based on an average daily volume of 1,162,246 shares, the short-interest ratio is currently 0.0 days. Currently, 1.6% of the shares of the stock are short sold.

NewGenIvf Group Trading Down 1.1%

Shares of NIVF stock traded down $0.01 on Wednesday, hitting $0.80. 53,596 shares of the stock traded hands, compared to its average volume of 683,125. The company has a current ratio of 3.43, a quick ratio of 3.37 and a debt-to-equity ratio of 0.17. NewGenIvf Group has a twelve month low of $0.69 and a twelve month high of $1,980.08. The firm’s 50-day moving average price is $1.54 and its two-hundred day moving average price is $12.78.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on NIVF shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of NewGenIvf Group in a report on Wednesday, January 28th. Wall Street Zen raised shares of NewGenIvf Group to a “hold” rating in a research note on Saturday, December 6th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has an average rating of “Sell”.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.